Please provide your email address to receive an email when new articles are posted on . Injectable collagenase clostridium histolyticum has revolutionized treatment of Dupuytren’s contracture as the ...
PALO ALTO, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development ...
SAN DIEGO, Sept. 23, 2025 /PRNewswire/ -- Ventoux Biosciences, a biotechnology company developing disease-modifying therapies for fibrotic conditions, today announced the issuance of a U.S. patent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback